Literature DB >> 16625228

Management of hypotension and low systemic blood flow in the very low birth weight neonate during the first postnatal week.

I Seri1.   

Abstract

Systemic hypotension during the first postnatal week is associated with increased mortality and morbidity in the very low birth weight (VLBW) neonate. Hypotension is generally defined as blood pressure below the fifth percentile of the gestational- and postnatal-age dependent blood pressure norms. Recent studies indicate that in most VLBW neonates, cerebral blood flow autoregulation is indeed lost when blood pressure reaches the fifth percentile. Treatment of the circulatory compromise should address the primary pathogenic factor(s) of the condition (hypovolemia, myocardial compromise, failure of vasoregulation or a combination of factors). Recent findings also suggest that vasopressor resistance can be treated with a brief course of low-dose hydrocortisone. However, due to the short- and potential long-term side effects of early hydrocortisone treatment, its use should be restricted to neonates with vasopressor-resistant hypotension. Finally, concomitant administration of hydrocortisone with indomethacin should be avoided due to the increased incidence of gastrointestinal perforations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625228     DOI: 10.1038/sj.jp.7211464

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  13 in total

1.  Hydrocortisone for refractory hypotension of very low birth weight infant with patent ductus arteriosus: a case report.

Authors:  Hyun Young Lee; Sang Hun Kim; Ki Tae Jung; Keum Young So
Journal:  J Anesth       Date:  2011-10-20       Impact factor: 2.078

2.  Salivary Cortisol Based Early ACTH Test for Identifying Adrenal Insufficiency in Low Birth Weight Infants.

Authors:  Ori Hochwald; Liisa Holsti; Horacio Osiovich
Journal:  Indian J Pediatr       Date:  2016-06-14       Impact factor: 1.967

3.  Noradrenaline in preterm infants with cardiovascular compromise.

Authors:  Kirsten Rowcliff; Koert de Waal; Abdel-Latif Mohamed; Tejasvi Chaudhari
Journal:  Eur J Pediatr       Date:  2016-10-15       Impact factor: 3.183

4.  Use of Vasopressin in Neonatal Intensive Care Unit Patients With Hypotension.

Authors:  Mengwei Ni; Jeffrey R Kaiser; Brady S Moffett; Christopher J Rhee; Jennifer Placencia; Kimberly L Dinh; Joseph L Hagan; Danielle R Rios
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

Review 5.  Current Challenges in Neonatal Resuscitation: What is the Role of Adrenaline?

Authors:  Roberto Antonucci; Luca Antonucci; Cristian Locci; Annalisa Porcella; Laura Cuzzolin
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

6.  Development and Validation of a Dynamic Nomogram to Predict the Risk of Neonatal White Matter Damage.

Authors:  Wenjun Cao; Chenghan Luo; Mengyuan Lei; Min Shen; Wenqian Ding; Mengmeng Wang; Min Song; Jian Ge; Qian Zhang
Journal:  Front Hum Neurosci       Date:  2021-02-23       Impact factor: 3.169

7.  Delayed diagnosis of spontaneous intestinal perforation among very low birth weight neonates: A single center experience.

Authors:  Doron J Kahn; Sandra Gregorisch; Jill S Whitehouse; Paul D Fisher
Journal:  J Perinatol       Date:  2019-08-28       Impact factor: 3.225

Review 8.  Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review.

Authors:  Prakasham Rumajogee; Tatiana Bregman; Steven P Miller; Jerome Y Yager; Michael G Fehlings
Journal:  Front Neurol       Date:  2016-04-25       Impact factor: 4.003

9.  Prone sleeping affects cardiovascular control in preterm infants in NICU.

Authors:  Kelsee L Shepherd; Flora Y Wong; Alexsandria Odoi; Emma Yeomans; Rosemary S C Horne; Stephanie R Yiallourou
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

10.  Challenges in understanding the impact of blood pressure management on cerebral oxygenation in the preterm brain.

Authors:  Aminath Azhan; Flora Y Wong
Journal:  Front Physiol       Date:  2012-12-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.